ATOSSA THERAPEUTICS, INC. — Director's Dealing 2013

May 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2013-05-07

Reporting Person: CROSS ALEXANDER D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-07	Stock Option (right to buy)	$6.595	A	41243	Acquired	2023-05-07	Common Stock (41243)	Direct
2013-05-07	Stock Option (right to buy)	$6.595	A	41243	Acquired	2023-05-07	Common Stock (41243)	Direct

Footnotes

F1: The option, which was granted for prior service on the Board of Directors, was fully vested and exercisable as of the date of grant.

F2: The option, which was granted for future service on the Board of Directors, shall vest with respect to 25% of the underlying shares quarterly over the next year.